{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:59:16Z","timestamp":1790351956527,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05161-4","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:34:30Z","timestamp":1783305270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic overshadowing in primary progressive multiple sclerosis with coexisting tethered cord syndrome and long-standing urological dysfunction: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9692-570X","authenticated-orcid":false,"given":"Taleb","family":"Alsalloum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Alsamman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahma","family":"Alkerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghiath","family":"Alassad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"5161_CR1","first-page":"S15","volume":"19","author":"MJ Tullman","year":"2013","unstructured":"Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 2013;19:S15\u201320. 2 Suppl.","journal-title":"Am J Manag Care"},{"key":"5161_CR2","doi-asserted-by":"publisher","unstructured":"Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun vol. 2014;48\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.022.","DOI":"10.1016\/j.jaut.2014.01.022"},{"issue":"10","key":"5161_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4.","journal-title":"Lancet Neurol"},{"issue":"4","key":"5161_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00002517-200008000-00008","volume":"13","author":"S Yamada","year":"2000","unstructured":"Yamada S, Lonser RR. Adult tethered cord syndrome. J spinal disorders vol. 2000;13(4):319\u201323. https:\/\/doi.org\/10.1097\/00002517-200008000-00008.","journal-title":"J spinal disorders vol"},{"issue":"3","key":"5161_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000098836","volume":"43","author":"SM Lew","year":"2007","unstructured":"Lew SM, Kothbauer KF. Tethered cord syndrome: an updated review. Pediatr Neurosurg vol. 2007;43(3):236\u201348. https:\/\/doi.org\/10.1159\/000098836.","journal-title":"Pediatr Neurosurg vol"},{"issue":"4","key":"5161_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41582-025-01181-9","volume":"22","author":"R Sakakibara","year":"2026","unstructured":"Sakakibara R, et al. Urogenital dysfunction in neurological diseases. Nat Reviews Neurol vol. 2026;22(4):226\u201338. https:\/\/doi.org\/10.1038\/s41582-025-01181-9.","journal-title":"Nat Reviews Neurol vol"},{"issue":"8","key":"5161_CR7","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/nau.24469","volume":"39","author":"HA Roy","year":"2020","unstructured":"Roy HA, et al. Assessment of patients with lower urinary tract symptoms where an undiagnosed neurological disease is suspected: A report from an International Continence Society consensus working group. Neurourol urodynamics vol. 2020;39(8):2535\u201343. https:\/\/doi.org\/10.1002\/nau.24469.","journal-title":"Neurourol urodynamics vol"},{"key":"5161_CR8","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMp1903078","volume":"380","author":"LI Iezzoni","year":"2019","unstructured":"Iezzoni LI. Dangers of Diagnostic Overshadowing. New Engl J Med vol. 2019;380:2092\u20133. https:\/\/doi.org\/10.1056\/NEJMp1903078.","journal-title":"New Engl J Med vol"},{"key":"5161_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00415-025-13303-w","volume":"272","author":"U Leitner","year":"2025","unstructured":"Leitner U, Chew SH, Blanch J, et al. Characteristics of MRI lesions in AQP4 antibody-positive NMOSD, MOGAD, and multiple sclerosis: a systematic review and meta-analysis. J Neurol. 2025;272:560. https:\/\/doi.org\/10.1007\/s00415-025-13303-w.","journal-title":"J Neurol"},{"issue":"1","key":"5161_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jnnp-2025-336694","volume":"97","author":"V-S Tseriotis","year":"2025","unstructured":"Tseriotis V-S, et al. MRI lesion distribution criteria for MS, NMOSD and MOGAD differentiation: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry vol. 2025;97(1):59\u201370. https:\/\/doi.org\/10.1136\/jnnp-2025-336694. 12 Dec.","journal-title":"J Neurol Neurosurg Psychiatry vol"},{"issue":"3","key":"5161_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban X, et al. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. New Engl J Med vol. 2017;376(3):209\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1606468.","journal-title":"New Engl J Med vol"},{"issue":"7","key":"5161_CR12","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1007\/s00415-022-10989-0","volume":"269","author":"C Alcal\u00e1","year":"2022","unstructured":"Alcal\u00e1 C, et al. Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study. J Neurol vol. 2022;269(7):3676\u201381. https:\/\/doi.org\/10.1007\/s00415-022-10989-0.","journal-title":"J Neurol vol"},{"key":"5161_CR13","doi-asserted-by":"publisher","unstructured":"Saylor D et al. Recommendations for essential medicines for multiple sclerosis in low-resource settings. Multiple sclerosis (Houndmills, Basingstoke, England) 31,4 (2025): 464\u201373. https:\/\/doi.org\/10.1177\/13524585241308134","DOI":"10.1177\/13524585241308134"},{"key":"5161_CR14","doi-asserted-by":"publisher","first-page":"106878","DOI":"10.1016\/j.msard.2025.106878","volume":"105","author":"N Rijke","year":"2026","unstructured":"Rijke N, et al. Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings. Multiple Scler Relat disorders. 2026;105:106878. https:\/\/doi.org\/10.1016\/j.msard.2025.106878.","journal-title":"Multiple Scler Relat disorders"},{"issue":"2","key":"5161_CR15","doi-asserted-by":"publisher","first-page":"e00861","DOI":"10.1016\/j.neurot.2026.e00861","volume":"23","author":"G Ismail","year":"2026","unstructured":"Ismail G, et al. The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients. Neurotherapeutics: J Am Soc Experimental Neurother vol. 2026;23(2):e00861. https:\/\/doi.org\/10.1016\/j.neurot.2026.e00861.","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother vol"},{"key":"5161_CR16","doi-asserted-by":"publisher","unstructured":"Hashimoto J, et al. Tethered cord syndrome in an adult with filum terminale lipoma: A case report. Surg Neurol Int Vol. Oct. 2024;15 375(11). https:\/\/doi.org\/10.25259\/SNI_708_2024.","DOI":"10.25259\/SNI_708_2024"},{"key":"5161_CR17","doi-asserted-by":"publisher","unstructured":"Ohmae K, et al. A Case of Surgically Treated Adult Split Cord Malformation Type 2 with Tethered Cord Syndrome. NMC case report journal. 28 Jan. 2025;12 1\u20135. https:\/\/doi.org\/10.2176\/jns-nmc.2024-0164.","DOI":"10.2176\/jns-nmc.2024-0164"},{"key":"5161_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/iju5.70032","volume":"8","author":"T Hyuga","year":"2025","unstructured":"Hyuga T, et al. Adult Manifestation of Lower Urinary Tract Dysfunction as Daytime Urinary Incontinence and Nocturnal Enuresis in a Case With Spinal Lipoma. IJU case reports. 23 Apr. 2025;8:4 334\u20137. https:\/\/doi.org\/10.1002\/iju5.70032.","journal-title":"23 Apr"},{"key":"5161_CR19","doi-asserted-by":"publisher","unstructured":"Jamil A, Banerjee A, Amin S et al. August 08,. (2025) Progressive Multiple Sclerosis Presenting With Obstructive Uropathy and Acute Kidney Injury: A Case Report. Cureus 17(8): e89643. https:\/\/doi.org\/10.7759\/cureus.89643.","DOI":"10.7759\/cureus.89643"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05161-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05161-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05161-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:02:36Z","timestamp":1790348556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05161-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5161"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05161-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was waived by the Institutional Review Board of the University of Hama because this manuscript reports a single de-identified case and did not involve experimental intervention beyond routine clinical care. The work was conducted in accordance with the Declaration of Helsinki. Written informed consent to participate was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of clinical details and accompanying images was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"610"}}